SCHEMBL500537

SCHEMBL500537

COc1c(N2C[C@H](CNC3CC3)[C@@H](C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 9/20 0.64
HPGD P15428 4/20 0.64
ALDH1A1 P00352 4/20 0.64
KCNH2 Q12809 3/20 0.64
TDP1 Q9NUW8 3/20 0.64
HSD17B10 Q99714 2/20 0.64
POLB P06746 2/20 0.64
PRKD3 O94806 1/20 0.64
ALOX15 P16050 1/20 0.64
OPRM1 P35372 1/20 0.64
CLK2 P49760 1/20 0.64
CLK4 Q9HAZ1 1/20 0.64
LMNA P02545 2/20 0.60
MEN1 O00255 1/20 0.60
KMT2A Q03164 1/20 0.60
NPSR1 Q6W5P4 1/20 0.56
CYP2C19 P33261 1/20 0.56
L3MBTL1 Q9Y468 1/20 0.56
ATM Q13315 1/20 0.55
GSK3B P49841 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL500734 1.00 KDM4E (0.64) KDM4EHPGDALDH1A1KCNH2TDP1
SCHEMBL500536 1.00 KDM4E (0.64) KDM4EHPGDALDH1A1KCNH2TDP1
SCHEMBL500290 1.00 KDM4E (0.64) KDM4EHPGDALDH1A1KCNH2TDP1
SCHEMBL500291 1.00 KDM4E (0.64) KDM4EHPGDALDH1A1KCNH2TDP1
SCHEMBL501763 0.92 KCNH2 (0.63) KDM4EHPGDALDH1A1KCNH2TDP1
SCHEMBL501167 0.92 KCNH2 (0.63) KDM4EHPGDALDH1A1KCNH2TDP1
SCHEMBL501189 0.92 KCNH2 (0.63) KDM4EHPGDALDH1A1KCNH2TDP1
SCHEMBL501168 0.92 KCNH2 (0.63) KDM4EHPGDALDH1A1KCNH2TDP1
SCHEMBL501188 0.92 KCNH2 (0.63) KDM4EHPGDALDH1A1KCNH2TDP1
SCHEMBL500594 0.91 KDM4E (0.53) KDM4EHPGDALDH1A1KCNH2TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1666477-B1 7-(4-SUBSTITUTED 3- CYCLOPROPYLAMINOMETHYL-1- PYRROLIDINYL) Q UINOLONECARBOXYLIC ACID DERIVATIVE KYORIN SEIYAKU KK (JP) 2013-07-03 EP disclosed
US-8106072-B2 7- (4-substituted-3-cyclopropylaminomethyl-1-pyrrolidinyl) quinolonecarboxylic acid derivative KYORIN PHARMACEUTICAL CO., LTD. (JP) 2012-01-31 US disclosed
US-20090176824-A1 7- (4-substituted-3-cyclopropylaminomethyl-1-pyrrolidinyl) quinolonecarboxylic acid derivative technical field ASAHINA YOSHIKAZU 2009-07-09 US disclosed
US-7514451-B2 7-(4-Substituted-3-cyclopropylaminomethyl-1 pyrrolidinyl) quinolonecarboxylic acid derivative KYORIN PHARMACEUTICAL CO., LTD. (JP) 2009-04-07 US disclosed
US-20060281779-A1 7-(4-Substituted-3-cyclopropylaminomethyl-1 pyrrolidinyl) quinolonecarboxylic acid derivative KYORIN PHARMACEUTICAL CO., LTD. (JP) 2006-12-14 US disclosed
EP-1666477-A1 7-(4-SUBSTITUTED 3- CYCLOPROPYLAMINOMETHYL-1- PYRROLIDINYL) Q UINOLONECARBOXYLIC ACID DERIVATIVE Kyorin Pharmaceutical Co., Ltd. (JP) 2006-06-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090176824-A1 7- (4-substituted-3-cyclopropylaminomethyl-1-pyrrolidinyl) quinolonecarboxylic acid derivative technical field CLPP, PRSS1, FOSB KDM4E 1507/4885HPGD 1391/4885ALDH1A1 2406/4885
US-20060281779-A1 7-(4-Substituted-3-cyclopropylaminomethyl-1 pyrrolidinyl) quinolonecarboxylic acid derivative RPS27L, RPS7, RPSA KDM4E 1345/4885HPGD 1358/4885ALDH1A1 2601/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.